MedTrace Logo

Inflammatory Bowel Disease and Thromboembolic Events

NCT05162339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2021-12-17

No results posted yet for this study

Summary

The main objective was to demonstrate the existence and importance of hypercoagulability in patients with IBD, by determining the prevalence of changes in coagulation parameters and evaluating the impact of these changes on the occurrence of thromboembolic events.

Conditions

  • Inflammatory Bowel Diseases
  • Thromboembolism
  • Coagulation Disorder

Interventions

OTHER

No intervention was made

No intervention was made

Sponsors & Collaborators

  • Portuguese IBD Group

    collaborator UNKNOWN

  • Centro Hospitalar Tondela-Viseu

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162339 on ClinicalTrials.gov